A
Aruna Biomedical
Development laboratory that specializes in creating medical technology
About Aruna Biomedical
Aruna Bio is a biotechnology company specializing in the development of neural exosome-based biologics aimed at treating central nervous system (CNS) disorders. The company primarily focuses on conditions such as stroke, traumatic brain injuries, and spinal cord injuries. Operating in the biopharmaceutical market, Aruna Bio serves healthcare providers and patients who require advanced therapeutic solutions for neurological diseases. The business model revolves around leveraging proprietary neural exosomes, which are naturally occurring biologics capable of crossing the blood-brain barrier to target and repair diseased cells. This innovative approach has shown promising results in preclinical studies, demonstrating the potential to enhance the nervous system's self-repair mechanisms, leading to both structural and functional benefits. Aruna Bio generates revenue through the development and commercialization of these exosome-based therapies, as well as potential partnerships and licensing agreements with other pharmaceutical companies.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2003
- Headquarters
- Athens, United States
- Employees
- 28
- Open positions
- None listed
- Dealroom signal
- 59.0/100
- Industry
- Health
- Sub-industry
- BioTechnology, Medical Devices
- Sector
- Biotech & Life Sciences, Biotechnology, Neurology, Spinout, Biotech and Pharma, DT and LS, science-based
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| GRANT✓Other financing | Oct 2019 | $4.5M | — | Small Business Innovation Research | — |
| EARLY VC✓Equity / VC | Jul 2019 | $13M | $52M | Eshelman Ventures | — |
Growth signals
Latest recorded traffic for Aruna Biomedical is 240 monthly website visits. Aruna Biomedical's team declined 9.7% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
Series A1 investor entered at this stage
Eshelman Ventures
Other known investors1 additional known investor
- UGUniversity of Georgia
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Aruna Biomedical on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Aruna Biomedical’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.